name,sequence,what disease to cure,target(s),year-of-discovery,other notes
Insulin,GIVEQCCTSICSLYQLENYCN,Diabetes,Insulin receptor,1921,First peptide hormone discovered
Exenatide,HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS,Type 2 diabetes,GLP-1 receptor,1992,Derived from the saliva of the Gila monster
Glucagon,HSQGTFTSDYSKYLDSRRAQDFVQWLMNT,Severe hypoglycemia,Glucagon receptor,1923,Used in emergency treatment of hypoglycemia
Oxytocin,CYIQNCPLG,"Induction of labor, Control of postpartum bleeding",Oxytocin receptor,1953,"A hormone that acts on organs in the body and as a chemical messenger in the brain, controlling key aspects of the reproductive system."
Vasopressin,CYFQNCPRG,"Diabetes insipidus, Esophageal varices bleeding",Vasopressin receptors,1951,Regulates water balance in the body and causes blood vessels to constrict.
Octreotide,DFNWKLLPEN,"Acromegaly, Tumor symptoms in carcinoid syndrome",Somatostatin receptor,1979,"Mimics natural somatostatin pharmacologically, more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone."
Ziconotide,N/A,Severe chronic pain,N-type calcium channels,1987,"First non-opioid medication for severe chronic pain, administered via intrathecal infusion."
Leuprolide,Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt,"Prostate cancer, Endometriosis, Uterine fibroids",GnRH receptor,1973,"Acts as a GnRH agonist, initially increasing and then significantly decreasing the release of gonadotropins and sex hormones."
Eptifibatide,Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2,"Acute coronary syndrome, Percutaneous coronary intervention",Glycoprotein IIb/IIIa receptor,1991,An anticoagulant that inhibits platelet aggregation.
Liraglutide,HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR,"Type 2 diabetes, Obesity",GLP-1 receptor,2009,"An analog of human glucagon-like peptide-1 (GLP-1), it enhances the secretion of insulin and suppresses the release of glucagon."
Dulaglutide,Not specified (GLP-1 receptor agonist),Type 2 diabetes,GLP-1 receptor,2014,A long-acting GLP-1 receptor agonist that improves glycemic control in patients with type 2 diabetes.
Semaglutide,Not specified (GLP-1 receptor agonist),"Type 2 diabetes, Obesity",GLP-1 receptor,2017,Another GLP-1 receptor agonist that can be used for the treatment of type 2 diabetes and as an aid in weight loss for adults with obesity.
Bortezomib,Not specified (Boronated peptide),"Multiple myeloma, Mantle cell lymphoma",Proteasome,2003,A proteasome inhibitor that disrupts cell cycle control and induces apoptosis in cancer cells.
Goserelin,Not specified (Synthetic decapeptide),"Prostate cancer, Breast cancer",GnRH receptor,1980s,"Similar to Leuprolide, used to treat hormone-sensitive cancers of the prostate and breast by inhibiting sex hormone production."
Carbetocin,Not specified (Oxytocin analog),Autism spectrum disorders (ASD) (research phase),Oxytocin receptor,2010s,An analog of oxytocin being researched for potential to improve social functioning in individuals with ASD.
Selank,Thr-Lys-Pro-Arg-Pro-Gly-Pro,"Anxiety, Depression (used in some countries)",Unknown; believed to modulate BDNF and other systems,2000s,"A synthetic peptide with anxiolytic properties, used in some countries."
Semax,Met-Glu-His-Phe-Pro-Gly-Pro,"Cognitive disorders, ADHD, Stroke recovery (research phase or used in some countries)",Unknown; appears to have neuroprotective and cognitive-enhancing effects,1980s-1990s,Studied for potential in improving cognitive function and neuroprotection.
